2006 Meeting Overview
Deadline for abstracts: November 15, 2005
The integration of epidemiologic and molecular research has advanced knowledge on genetic and epigenetic pathways of carcinogenesis and the molecular signatures of premalignant and malignant transformation. Early cancer detection and risk assessment are being translated into clinical applications for screening of individuals at high-risk because of environmental exposures, family history and genetic susceptibility. The scientific program aims to elucidate how this knowledge is being employed in the control and prevention of cancer.
Plenary presentations illuminate the manner in which molecular events, cellular, chromosomal and DNA aberrations, genetic defects and environmental exposures influence the development and control of cancer. Focus lectures and expert panels critically assess information on integrated interventions dealing with multiple risk factors and approaches to primary prevention for evidence-based practices.
The scope of the program includes identification and management of cancer-prone individuals, the promotion of healthy lifestyle, tobacco control and the delivery of public health and socio-economic measures. Reports on utilization of targeted biological agents, pharmacogenomics and biomedical instrumentation for the early detection of occult and overt tumorigenesis will highlight innovative strategies effective in particular organ systems.
Experts from academia, industry and government, leading the work in more than 50 counties, will communicate this up-to-date understanding of the rapid strides in preventive oncology.
The meeting is intended to foster cooperation between basic science, clinical and public health investigators in universities and other research groups engaged in biotechnology and biomedicine, validation studies, translational research and technology transfer.
The information being presented will be valuable to those engaged in biomedical technologies, basic science, experimental and clinical oncology, biochemistry, molecular biology and medicine, pathology, immunology, genetics and public health.
The program of papers and abstracts of presentations will be published in the journal, Cancer Detection and Prevention (Elsevier Science) and will be available online at this website.
*A question/answer period follows each presentation. Supplemental discussion is foreseen during the poster sessions.
Basic investigators, clinical oncologists and nonmedical scientists who are working in research and development areas that have implications for cancer detection and control.
The meeting is an initiative of the International Society for Preventive Oncology (ISPO). The Society has applied for cosponsorship of the scientific program by the World Health Organization, the International Agency for Research on Cancer, the French National League Against Cancer, the French Federation of Cancer Centers and the European Cancer Prevention Organization.
Application for award of 35 Continuing Medical Education credit hours is pending by the University of Massachusetts Medical School.
The International Society for Preventive Oncology plans for up to 25 grants each in the amount of $200 for prize-winning presentations judged excellent contributions to the program.
On This Page
This Page Last Updated
07 July 2005